2015-10-1 · Comparative schedules of the CD34 selection process with CliniMACS Plus and CliniMACS Prodigy. White gray and black bars column height depicts time shading marks manual automatic-supervised and autonomous preparation steps respectively. Process time is similar for both protocols but hands-on time with Prodigy is much reduced.
2020-4-27 · Peripheral blood mononuclear cells will be collected from the donor and loaded onto our Miltenyi Biotec CliniMACS Prodigy® or CliniMACS® Plus where they will be stimulated in vitro with Epstein-Barr viral-specific antigen(s). The cells are then immunomagnetically labeled with interferon gamma via the cytokine capture system captured and infused.
munomagnetic beads. The CliniMACS Plus semi-automatic instrument from Miltenyi Biotec has been used for decades for clinical-scale enrichment of CD34 cells in a closed and sterile system.1 Miltenyi Biotec has recently developed a successor to the CliniMACS Plus the CliniMACS Prodigy which is a fully automated device with limited operator in-
2020-1-21 · The CliniMACS CD34 Reagent System is indicated for processing hematopoietic progenitor cells collected by apheresis (HPC Apheresis) from an allogeneic HLA-identical sibling donor to
Find many great new used options and get the best deals for Miltenyi Biotec Clinimacs Plus Instrument Clinical-scale Cell Selection Manufact at the best online prices at eBay Free shipping for many products
2019-3-27 · ®CliniMACS Plus Protocol Processing time about 4.5h. Hands on. Open steps. Reformulation of end product. CliniMACS
2020-2-1 · CliniMACS plus cell preparative system. 2020-02-01. CliniMACS® Plus MACS . 50 100 .
2020-12-13 · CliniMACS Plus Instrument and Accessories. The CliniMACS is an automated cell-selection device based on MACS technology. It enables the operator to perform large-scale magnetic cell selection in a closed and sterile system (Fig. 4.42). The use of clinical-grade isolation or depletion of cells has grown dramatically over the past few years and
In the US the CliniMACS CD34 Reagent System including the CliniMACS Plus Instrument CliniMACS CD34 Reagent CliniMACS Tubing Sets TS and LS and the CliniMACS PBS/EDTA Buffer is FDA approved as a Humanitarian Use Device (HUD) authorized by U.S. Federal law for use in the treatment of patients with acute myeloid leukemia (AML) in first complete remission.
2020-11-12 · CliniMACS™ Plus system. NK cells were then cultured without feeder cells under xeno‑free conditions. After cells reached the desired volume and viable cell concentration they were transferred into a Xuri™ Cell Expansion System W25. At the end
2020-2-1 · CliniMACS plus cell preparative system. 2020-02-01. CliniMACS® Plus MACS . 50 100 .
2020-12-13 · CliniMACS Plus Instrument and Accessories. The CliniMACS is an automated cell-selection device based on MACS technology. It enables the operator to perform large-scale magnetic cell selection in a closed and sterile system (Fig. 4.42). The use of clinical-grade isolation or depletion of cells has grown dramatically over the past few years and
The CliniMACS Prodigy offers a flexible platform for cell processing applications enabling the magnetic separation of different cell types as well as customized cell processing protocols. The cell processing unit for fully automated washing fractionation and cultivation of cells represents an
The CliniMACS Plus Instrument has been developed to allow the automated separation of cells on a clinical-scale level in a closed and sterile system. Magnetic selection or depletion of labelled target cells for example from leukapheresis can be performed to isolate a desired cell population or for the specific removal of a given cell
munomagnetic beads. The CliniMACS Plus semi-automatic instrument from Miltenyi Biotec has been used for decades for clinical-scale enrichment of CD34 cells in a closed and sterile system.1 Miltenyi Biotec has recently developed a successor to the CliniMACS Plus the CliniMACS Prodigy which is a fully automated device with limited operator in-
The CliniMACS Plus Instrument has been developed to allow the automated separation of cells on a clinical-scale level in a closed and sterile system. Magnetic selection or depletion of labelled target cells for example from leukapheresis can be performed to isolate a desired cell population or for the specific removal of a given cell
2020-1-21 · The CliniMACS CD34 Reagent System is indicated for processing hematopoietic progenitor cells collected by apheresis (HPC Apheresis) from an allogeneic HLA-identical sibling donor to
2018-6-4 · CliniMACS Plus •The Prodigy offers a single device for CD34 cell selection unlike the CliniMACS Plus which requires other equipment •The Prodigy process is fully automated and this translates into a reduction in the time required of experienced laboratory staff •Our results suggest that the Prodigy can be used for the routine
2017-1-19 · CliniMACSCliniMACS Plus CliniMACS CliniMACS CliniMACS CliniMACS PlusCliniMACSCE
Item CliniMACS Plus Instrument. Company Miltenyi Biotec. Catalog Number 151-01.
2020-2-1 · CliniMACS plus cell preparative system. 2020-02-01. CliniMACS® Plus MACS . 50 100 .
Background aims Immunomagnetic enrichment of CD34 hematopoietic "stem" cells (HSCs) using paramagnetic nanobead coupled CD34 antibody and immunomagnetic extraction with the CliniMACS plus system is the standard approach to generating T-cell-depleted stem cell grafts. Their clinical beneficence in selected indications is established. Even though CD34 selected grafts are typically
2020-2-1 · CliniMACS plus cell preparative system. 2020-02-01. CliniMACS® Plus MACS . 50 100 .
2018-3-30 · The CliniMACS® Plus Instrument is an automated cell separation system based on MACS® Technology. It enables the operator to perform clinical-scale magnetic enrichment of target cells or depletion of unwanted cells in a closed and sterile system. CliniMACS Technology offers reliability and convenience in one compact benchtop instrument.
The user-friendly key components of the CliniMACS® Plus Instrument offer sophisticated applications for a whole variety of separations. The selected stem cells monocytes DCs NK cells B cells and T cell subsets allow research in the field of regenerative medicine adoptive immunotherapy and
The CliniMACS Plus Instrument has been developed to allow the automated separation of cells on a clinical-scale level in a closed and sterile system. Magnetic selection or depletion of labelled target cells for example from leukapheresis can be performed to isolate a desired cell population or for the specific removal of a given cell
2020-11-12 · CliniMACS™ Plus system. NK cells were then cultured without feeder cells under xeno‑free conditions. After cells reached the desired volume and viable cell concentration they were transferred into a Xuri™ Cell Expansion System W25. At the end
The median CD34 recovery was 83 (range 70-100). To achieve a sufficient number of CD34 cells we performed an additional CD34 enrichment procedure using the CliniMACS Plus for 3 patients. The B cell depletion was slightly less efficient with a median log reduction of -3.72 (range -2.83 to -4.20).
2020-1-21 · The CliniMACS CD34 Reagent System is indicated for processing hematopoietic progenitor cells collected by apheresis (HPC Apheresis) from an allogeneic HLA-identical sibling donor to
BQ+ Medical not only produce components for manufacturers all over the world, but also provide private label manufacturing for leading brand distributors in different countries.
8,Cheye Road,Songjiang District,Shanghai 201611 China.
Tel: 86-021-57743953
Email: [email protected]
Copyright © BQ PLUS MEDICAL CO., LTDSitemap | Contact Us |
